Intraoperative red cell salvage in head and neck surgery

Nusrath, M.A.; Edge, C.J.; Ahmed-Nusrath, Anjum

doi:10.1016/j.bjoms.2011.04.076

Cited by 2 publications

(2 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Autotransfusion is a way to avoid or at least minimize patients' exposure to allogeneic blood. Although a disposable system is needed for autotransfusion, it is more cost effective than a single unit of donated red cells [14] . In 1874, the first successful autotransfusion was completed by a German physician, Hueter, who transfused 350 mL of autologous blood into the left tibial artery of a patient with frost-gangrene on both feet.…”

Section: Is Blood Salvage Safe For Tumor Patients?mentioning

confidence: 99%

“…Particularly, in April 2008, a recommendation from the National Institute for Health and Clinical Excellence (NICE) approved the use of autologous blood transfusion in cancer surgery, specifically prostatectomy and cystectomy [33] . Additionally, ICS was so well established in other surgical specialties, that NICE endorsed its usage in urological cancer in 2012 [14] . Not only can blood salvage avoid the shortcomings of allogeneic blood transfusion mentioned above, it can also markedly reduce the probability of tumor recurrence and mortality, and save valuable blood resources.…”

Section: Is Blood Salvage Safe For Tumor Patients?mentioning

confidence: 99%

See 1 more Smart Citation

Blood salvage, proper choice for tumor patients?

Zhou¹,

Huang²

2017

Blood and Genomics

View full text Add to dashboard Cite

Blood transfusion is frequently used in tumor patients. However, allogeneic blood transfusion have been claimed to be associated with an increased risk of negative outcomes, including transfusion reactions, fever, virus transmission, and alloimmunization. Other risks of homologous transfusion specific to the tumor patients are the potential deleterious effects on the recurrence of tumor and indefinite overall survival. On the contrary, autologous blood transfusion offers survival advantages to tumor patients and has been shown to minimize the occurrence of many detrimental allogeneic blood associated effects and complications. It also reduces the volume of banked blood needed and improves the prognosis of patients. However, the quality of salvaged blood is still a matter of debate, because it may contain tumor cells which are associated with potential detrimental effects such as metastasis. So, an advanced technology is needed to remove such contaminants to make autologous blood transfusion safer.

show abstract

Section: Is Blood Salvage Safe For Tumor Patients?mentioning

confidence: 99%

Section: Is Blood Salvage Safe For Tumor Patients?mentioning

confidence: 99%